Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Port

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Annals of Thoracic Surgery|September 1, 1996
Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survivalJ L Port, B Ng, J L Ellis, et al.
The Annals of Thoracic Surgery|November 1, 1995
Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma modelH Y Wang, B Ng, D Blumberg, et al.
The Annals of Thoracic Surgery|January 1, 1995
Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in ratsB Ng, J T Lenert, B Weksler, et al.
Surgery|September 1, 1996
Depletion of high energy phosphate compouds in the tumor-bearing state and reversal after tumor resectionS N Hochwald, L E Harrison, J L Port, et al.
The Annals of Thoracic Surgery|October 1, 1995
Thymoma: a multivariate analysis of factors predicting survivalD Blumberg, J L Port, B Weksler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancerN K Altorki, R S Keresztes, J L Port, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Annals of Thoracic Surgery|September 1, 1996
Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survivalJ L Port, B Ng, J L Ellis, et al.
The Annals of Thoracic Surgery|November 1, 1995
Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma modelH Y Wang, B Ng, D Blumberg, et al.
The Annals of Thoracic Surgery|January 1, 1995
Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in ratsB Ng, J T Lenert, B Weksler, et al.
Surgery|September 1, 1996
Depletion of high energy phosphate compouds in the tumor-bearing state and reversal after tumor resectionS N Hochwald, L E Harrison, J L Port, et al.
The Annals of Thoracic Surgery|October 1, 1995
Thymoma: a multivariate analysis of factors predicting survivalD Blumberg, J L Port, B Weksler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancerN K Altorki, R S Keresztes, J L Port, et al.
Pageof 2